General Partner at Polaris Partners. Focus includes healthcare, consumer products and energy.
Boston
Joined December 2012
- Tweets869
- Following223
- Followers2.5K
- Likes402
Amir Nashat retweeted
Very well deserved recognition for Yvonne and several other fantastic #biotech and #lifesciences leaders! Congratulations to all! #leadership
Congratulations to our President and COO Dr. Yvonne Greenstreet on being named a 2020 Women Who Mean Business honoree by @BosBizJournal. #AlnylamProud bizjournals.com/boston/news/…
Amir Nashat retweeted
It’s wonderful to see Jennifer and Emmanuelle recognized with the 2020 Nobel Prize in chemistry. The seminal “Jinek et al.” paper they published together has been cited >9,500 times—approximately once every 8 hours since its publication in 2012. (1/3)
nobelprize.org/uploads/2020/…
Amir Nashat retweeted
1) There is a lot of talk about decaying antibodies. I would like to walk you through a few findings about antibodies to SARS-CoV-2 that we put on medRxiv on Friday. Ill do this slowly over the day (while being in nonstop conference calls). But I feel this needs to get out there.
Amir Nashat retweeted
Jnana cofounders Joanne Kotz (CEO) and Joel Barrish (CSO) share the road that led to today’s milestone collaboration with Roche: building the first company and drug discovery platform targeting SLC transporters. #SLCs jnanatx.com/the-gateway-blog…
Amir Nashat retweeted
Forced by the pandemic, health care plunges into the digital age - all it took was changing regulatory barriers- The Boston Globe bostonglobe.com/2020/06/12/m…
Amir Nashat retweeted
Volunteer efforts have popped up across the country to help ease the lingering isolation of the pandemic among older Americans, creating connections and unexpected friendships. nyti.ms/30uUz2R
Amir Nashat retweeted
For those who are interested in research-based solutions to stop police violence, here’s what you need to know - based on the facts and data. A thread. (1/x)
Amir Nashat retweeted
Covid19 testing in the U.S. continues to expand, and the positivity rate decline nationally.
Amir Nashat retweeted
BIDMC proud: research led by Dan Barouch, MD, PhD, Director of Virology and Vaccine Research, is on the front page of both the @BostonGlobe and @nytimes today. Learn more about the #COVID19 vaccine prototypes making headlines: bit.ly/3cNDAMx
Amir Nashat retweeted
IPI is officially fighting #COVID-19 with #SyntheticPeptides that neutralize #SARS-CoV-2 incorporated into engineered #nanostructures for use in disinfecting aerosols. Congrats to IPI’s Chris Bahl and Phil Demokritou @HarvardChanSPH for scoring @NSFgrant.
ALT Image of synthetic peptide bound to SARS-CoV-2 protein
Amir Nashat retweeted
.@GileadSciences CEO Daniel O’Day discusses with @matthewherper the latest news with remdesivir and why access to the treatment will not be an issue for #COVID19 patients. buff.ly/3eYxomq
Amir Nashat retweeted
CA has procured nearly 11,000 rooms to protect our homeless population from #COVID19.
Today, we announced Motel 6 is setting aside up to 5,025 rooms at 47 locations in 19 counties like the one we’re in front of today. We must continue to protect our homeless from this disease.
Amir Nashat retweeted
WOW. I. HAVE. NO. WORDS. 😭
Sweden's Princess Sofia has announced she's reducing her Royal duties so she can volunteer at local hospital. She has already completed intensive training to prepare for it. In her new role, she'll be disinfecting, cleaning, & working in the kitchen.
Amir Nashat retweeted
Yes, patients do recover from #COVID19 #ARDS. And yes, my #ICU team does do an #extubation dance every time we liberate someone from a #Ventilator. #ARDSAvengers #coronavirus #bestteamever @uclaimchiefs @UCLAHealth @atscommunity @GiladJaffe @HungryDes @NoCoughEng
Amir Nashat retweeted
Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies ir.fatetherapeutics.com/news…
Amir Nashat retweeted
BIO member companies are working around the clock to develop solutions to #COVID19. Learn about one of those efforts from @Regeneron and @Sanofi in @WSJ: buff.ly/2vnp9P0
Amir Nashat retweeted
.@BlackThornRX Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders biospace.com/article/release…
Amir Nashat retweeted
Research pact between Syros Pharma, Global Blood seeks new drugs to treat sickle cell disease statnews.com/2019/12/18/rese…
Amir Nashat retweeted
Of 2,879 drugs in the Medicare Part D drug spending dashboard in 2017, 60% had list prices that rose faster than inflation between ‘16 and ‘17 kff.org/medicare/issue-brief…
Amir Nashat retweeted
Check out our paper on: How ZO Scaffolding Proteins Self-Organize Tight Junction Assembly via Phase Separation
authors.elsevier.com/a/1Z~ff…
Big thanks to Oliver Beutel and all authors for this great work! And to the facilities @mpicbg for their awesome support.